Singapore markets closed
Straits Times Index
3,230.55 +21.37 (+0.67%) Nikkei
26,781.68 +176.84 (+0.66%) Hang Seng
20,697.36 +581.16 (+2.89%) FTSE 100
7,585.46 +20.54 (+0.27%) BTC-USD
28,893.78 +410.82 (+1.44%) CMC Crypto 200
625.79 -3.71 (-0.59%)
Bristol-Myers Squibb Company (BMY)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 77.59 |
| Open | 77.31 |
| Bid | 76.25 x 1800 |
| Ask | 76.35 x 800 |
| Day's range | 75.46 - 77.44 |
| 52-week range | 53.22 - 78.61 |
| Volume | |
| Avg. volume | 15,212,149 |
| Market cap | 162.107B |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | 26.97 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.16 (2.84%) |
| Ex-dividend date | 31 Mar 2022 |
| 1y target est | N/A |
- Zacks
Iovance (IOVA) Down After Announcing Data From Melanoma Study
Results from a cohort of the phase II study evaluating Iovance's (IOVA) melanoma candidate were not as superior as data from another cohort of the same study.
- Zacks
Mirati (MRTX) Down 23% on Mixed Data From Lung Cancer Study
Mirati (MRTX) posts positive data from a phase II study evaluating its lung cancer candidate adagrasib. However, the drug caused side-effects in a large number of study participants.
- Zacks
J&J (JNJ) Carvykti Gets EU Nod for Advanced Multiple Myeloma
The European Commission approved J&J's (JNJ) BCMA-directed CAR-T cell therapy, Carvykti to treat patients with multiple myeloma who have already received multiple treatments.
© 2022 Yahoo. All rights reserved.
